In such cases, a combined approach using miR-634 ointment and EGFR inhibitors could potentially enhance both the effectiveness and the length of response in treating locally advanced cutaneous squamous cell carcinoma, compared to using EGFR inhibitors alone [67]. This evidence concerns the gene EGFR and cutaneous squamous cell carcinoma.